Skip to main content
Home
  • Twitter
  • Facebook
  • YouTube
  • Instagram
  • Blog
  • Contact
  • de
animals Animals
climate Climate Crisis
Conflict Regions
Culture
Democracy
Development & Aid
Economy
Education
energy Energy
environment Environment
Exemplary People
food Food & Agriculture
Globalization
Health
Human Rights
Men
military Military
nature Nature
News Media
nuclear weapons Nuclear Disarmament
Peace
Politics
Religions
Social Justice
Sustainability
Women
Youth
Useful Tools
Real News
Events

Other COVID-10 Drugs

  1. Home
  2. Health
  3. Info by Disease
  4. Infections
  5. Novel Coronavirus Guide
  6. COVID-19 DRUGS
Suggest a link
Cancel
  • From nasal vaccines to pills: the next defences against Covid - Guardian 15.08.22300496
  • Paxlovid rebound happens, though why and to whom are still a mystery - Stat News 02.08.22375902
  • Arthritis drug could help save Covid patients – study - Guardian 03.03.22277525
  • Doctors have an arsenal of Covid-19 treatments, but setbacks and shortages are undercutting options - StatNews 07.01.22274864
  • Investigating Antidepressants’ Surprising Effect on COVID Deaths - Scientific American 12.11.21262669
  • Pfizer pill significantly cuts risk of COVID-19 death, company says - Politico 05.11.21260911
  • Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop - Guardian 14.10.21257883
  • Why Merck’s Covid-19 pill molnupiravir could be so important - VOX 12.10.21257884
  • How antiviral pill molnupiravir shot ahead in the COVID drug hunt - Nature 08.10.21257881
  • 'Entirely unsurprising': Merck slammed for 4,000% markup of taxpayer-funded covid drug - CD 06.10.21257527
  • How Merck's antiviral pill could change the game for COVID-19 - Nat Geo 01.10.21256793
  • Merck’s COVID pill cuts deaths, hospitalisations by half: Report - Al Jazeera 01.10.21256525
  • Fraudulent ivermectin studies open up new battleground between science and misinformation - Guardian 24.09.21257773
  • Desperation, misinformation: how the ivermectin craze spread across the world - Guardian 24.09.21256001
  • India’s medicine makers in logistical ‘mess’ as coronavirus crisis disrupts pharmaceutical supply chain - SCMP 18.05.21246079
  • Coronavirus disease 2019 and cardiovascular system: A narrative review - Pub Med 03.06.20241469
  • Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - Lancet 09.04.21241475
  • Artificial intelligence can now design new antibiotics in a matter of days - Vox 03.04.21240790
  • With Great Caution, Scientists Seek Covid Treatments in Old Drugs - UNDARK 30.03.21240328
  • Arthritis drug that helps Covid ICU patients has wider benefits, trial finds - Guardian 11.02.21235855
  • Gout drug could reduce Covid hospital stays, new research finds - Guardian 04.02.21237884
  • Even with vaccines, we still need treatments for Covid. So what works? - Guardian 02.02.21237263
  • Relationship between antidepressants and severity of SARS-CoV-2 Omicron infection: a retrospective cohort study using real-world data - Lancet 27.02.23238136
  • SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - NCBI 04.03.20 201934
  • How COVID-19 is demanding a new look at Indigenous healing in the Amazon - The Humanitarian 26.08.20215335
  • Coronavirus: Madagascar pursues clinical trials of injectable remedy - The Africa Report 12.06.20212218
  • The Efficacy of Ivermectin Against COVID‑19 - Covid19criticalcare238890
  • About Us
    • FAQ
    • Endorsements
    • Privacy Policy
    • Disclaimer
    • Publisher
    • Press
  • Get Involved
    • What can I do?
    • Add a Link
    • Share knowledge
    • Donate
    • Contact us

Follow us

  • Twitter
  • Facebook
  • YouTube
  • Instagram
to top

share

Privacy
Details
Imprint | Privacy
Your selection from
The controller (Dr. Norbert Stute, Austria) would like to use the following services in order to process your personal data. Technologies such as cookies, localStorage, etc. can be used for personalization. This is not necessary for the use of the website, but allows us to interact with you more closely. If you wish, you can adjust or revoke your consent at any time via our privacy policy.
Other content (1 Service)
Integration of additional information
Switch to accept or reject the category Other content

X (Twitter)
Twitter International Unlimited Company, Ireland
All Detailsto X (Twitter)
All Detailsto X (Twitter)
Switch to accept or reject the service X (Twitter)
When accessing some sub-services of our website, additional personal services are processed. Processed data categories: technical connection data of the server access (IP address, date, time, requested page, browser information)data about the use of the website and the logging of clicks on individual elements. Purpose of processing: Selection of online advertising on other platforms, which are automatically selected using real-time bidding based on user behavior and provision of social media services. The legal basis for processing: Your consent according to Art. 6 (1) a GDPR. Data is transmitted: as joint controllers for Twitter International Unlimited Company, One Cumberland Place, Fenian Street Dublin 2, D02 AX07, Ireland. This may also mean a transfer of personal data to a country outside the European Union. The data is transmitted on the basis of your consent in accordance with Art. 6 Para. 1 lit a in conjunction with Art. 49 Para. 1 lit a GDPR. You were informed before you gave your consent that the USA does not have a level of data protection that corresponds to the standards of the EU. In particular, US secret services can access your data without you being informed and without you being able to take legal action against it.
Switch to accept or reject the service